Results 111 to 120 of about 87,420 (220)
Health Science Reports, Volume 9, Issue 8, August 2026.ABSTRACT Background Bloodstream infections (BSIs) pose a significant global health challenge, particularly in developing countries. Neonates are highly vulnerable due to underdeveloped immune systems and immature physical barriers, a risk amplified by poor hygiene and limited healthcare access in low‐ and middle‐income countries (LMICs), leading to an ...
Alex Odoom +4 more
wiley +1 more source
Journal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 2, Page 258-264, August 2026.Abstract Objectives Caregivers of infants with symptoms suggestive of gastroesophageal reflux (GER), such as regurgitation and excessive crying, often feel uncertain and seek treatment, though it is usually unnecessary. This study evaluated the effect of a decision aid on reducing caregivers’ preference for acid suppressive medication for infants ...
Anna de Geus +6 more
wiley +1 more source
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993), 2014 The eosinophilic gastroenteritis is a disease of unknown etiopathogenesis and rare presentation, with several clinical symptoms, ranging from mild episodes until nonspecific abdominal acute episodes of intestinal obstruction, which some times make it necessary urgent surgical treatment.
Ondina Marlene Garibay-Vargas +7 more
openaire +2 more sources
Non‐Cyclic Rozanolixizumab Administration in Complex Generalized Myasthenia Gravis
Muscle &Nerve, Volume 74, Issue 2, Page 422-426, August 2026.ABSTRACT Introduction/Aims Rozanolixizumab, an inhibitor of the neonatal Fc receptor (FcRn), is used to treat patients with generalized myasthenia gravis (gMG) refractory to standard therapies. However, the approved six‐week cyclic regimen may be associated with a “wearing‐off” effect and disease fluctuations. We evaluated the non‐cyclic administration
Marc Abi Aoun +6 more
wiley +1 more source
A case report on the long‐term use of teduglutide in a pediatric patient with short bowel syndrome
Nutrition in Clinical Practice, Volume 41, Issue 4, Page 1253-1259, August 2026.Abstract Short bowel syndrome (SBS) is the leading cause of intestinal failure, frequently necessitating long‐term parenteral nutrition (PN). Teduglutide (TED), a glucagon‐like peptide‐2 analog, has demonstrated efficacy in reducing PN dependence in both adults and children. However, long‐term data in pediatric populations remain limited.
Tsuyoshi Sakurai +8 more
wiley +1 more source
Medical Clinics of North America, 1982 Wolf, Jacqueline L., Schreiber, David S.
openaire +2 more sources
ChemistryOpen, Volume 15, Issue 8, August 2026.Psoralen (PSN) demonstrates significant dose‐dependent antiemetic activity in a copper sulfate–induced chick emesis model. Integrated in vivo and in silico analyses reveal reduced retching frequency, prolonged latency, and favorable multi‐receptor interactions with D2, 5‐HT3A, and muscarinic receptors, highlighting PSN as a promising multi‐target ...
Kishor Chandra +12 more
wiley +1 more source
Microbial Biotechnology, Volume 19, Issue 8, August 2026.This study evaluated the 3‐month safety and tolerability of the probiotic CP‐9 in healthy infants aged 6 to 36 months. The research confirmed that, under the conditions of this study, CP‐9 can safely enrich specific beneficial bacterium in the gut without any obvious short‐term safety signal. ABSTRACT Infancy represents a critical period for growth and
Liujing Zhang +15 more
wiley +1 more source
Planning Intermittent CalciNeurin Inhibitor Controls—The piCNIc Retrospective Cohort Study
Clinical Transplantation, Volume 40, Issue 8, August 2026.ABSTRACT Background Calcineurin inhibitors (CNIs) are essential in immunosuppressive therapy after solid organ transplantation (SOT). Their narrow therapeutic index and inter‐ and intra‐individual variability require therapeutic drug monitoring (TDM), but optimal monitoring frequency remains unclear.
Veronica Bellissimo +9 more
wiley +1 more source